FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296301595> ?p ?o ?g. }

• W4296301595 endingPage "1237" @default.
• W4296301595 startingPage "1220" @default.
• W4296301595 abstract "The optimal duration of antiplatelet therapy (APT) after coronary stenting in patients at high bleeding risk (HBR) presenting with an acute coronary syndrome remains unclear.The objective of this study was to investigate the safety and efficacy of an abbreviated APT regimen after coronary stenting in an HBR population presenting with acute or recent myocardial infarction.In the MASTER DAPT trial, 4,579 patients at HBR were randomized after 1 month of dual APT (DAPT) to abbreviated (DAPT stopped and 11 months single APT or 5 months in patients with oral anticoagulants) or nonabbreviated APT (DAPT for minimum 3 months) strategies. Randomization was stratified by acute or recent myocardial infarction at index procedure. Coprimary outcomes at 335 days after randomization were net adverse clinical outcomes events (NACE); major adverse cardiac and cerebral events (MACCE); and type 2, 3, or 5 Bleeding Academic Research Consortium bleeding.NACE and MACCE did not differ with abbreviated vs nonabbreviated APT regimens in patients with an acute or recent myocardial infarction (n = 1,780; HR: 0.83; 95% CI: 0.61-1.12 and HR: 0.86; 95% CI: 0.62-1.19, respectively) or without an acute or recent myocardial infarction (n = 2,799; HR: 1.03; 95% CI: 0.77-1.38 and HR: 1.13; 95% CI: 0.80-1.59; Pinteraction = 0.31 and 0.25, respectively). Bleeding Academic Research Consortium 2, 3, or 5 bleeding was significantly reduced in patients with or without an acute or recent myocardial infarction (HR: 0.65; 95% CI: 0.46-0.91 and HR: 0.71; 95% CI: 0.54-0.92; Pinteraction = 0.72) with abbreviated APT.A 1-month DAPT strategy in patients with HBR presenting with an acute or recent myocardial infarction results in similar NACE and MACCE rates and reduces bleedings compared with a nonabbreviated DAPT strategy. (Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen [MASTER DAPT]; NCT03023020)." @default.
• W4296301595 created "2022-09-19" @default.
• W4296301595 creator A5002707772 @default.
• W4296301595 creator A5004722731 @default.
• W4296301595 creator A5016340857 @default.
• W4296301595 creator A5026031312 @default.
• W4296301595 creator A5029674394 @default.
• W4296301595 creator A5030343009 @default.
• W4296301595 creator A5035239568 @default.
• W4296301595 creator A5035353168 @default.
• W4296301595 creator A5038774828 @default.
• W4296301595 creator A5039732411 @default.
• W4296301595 creator A5039789130 @default.
• W4296301595 creator A5045935466 @default.
• W4296301595 creator A5049648116 @default.
• W4296301595 creator A5051530432 @default.
• W4296301595 creator A5053194091 @default.
• W4296301595 creator A5056664302 @default.
• W4296301595 creator A5057812039 @default.
• W4296301595 creator A5059011787 @default.
• W4296301595 creator A5061359562 @default.
• W4296301595 creator A5061462083 @default.
• W4296301595 creator A5065253955 @default.
• W4296301595 creator A5069357648 @default.
• W4296301595 creator A5069456501 @default.
• W4296301595 creator A5069601173 @default.
• W4296301595 creator A5071273910 @default.
• W4296301595 creator A5073951189 @default.
• W4296301595 creator A5076782898 @default.
• W4296301595 creator A5091301686 @default.
• W4296301595 creator A5091436608 @default.
• W4296301595 date "2022-09-01" @default.
• W4296301595 modified "2023-10-15" @default.
• W4296301595 title "Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk" @default.
• W4296301595 cites W1981132890 @default.
• W4296301595 cites W2122779695 @default.
• W4296301595 cites W2140501627 @default.
• W4296301595 cites W2169387542 @default.
• W4296301595 cites W2331820709 @default.
• W4296301595 cites W2593571361 @default.
• W4296301595 cites W2754054868 @default.
• W4296301595 cites W2846895012 @default.
• W4296301595 cites W2900564308 @default.
• W4296301595 cites W2911481227 @default.
• W4296301595 cites W2953479758 @default.
• W4296301595 cites W2976166882 @default.
• W4296301595 cites W2988588188 @default.
• W4296301595 cites W3012004912 @default.
• W4296301595 cites W3035351100 @default.
• W4296301595 cites W3046549025 @default.
• W4296301595 cites W3162195278 @default.
• W4296301595 cites W3162810209 @default.
• W4296301595 cites W3193614870 @default.
• W4296301595 cites W3197102732 @default.
• W4296301595 cites W4214943375 @default.
• W4296301595 cites W4280548975 @default.
• W4296301595 doi "https://doi.org/10.1016/j.jacc.2022.07.016" @default.
• W4296301595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36137672" @default.
• W4296301595 hasPublicationYear "2022" @default.
• W4296301595 type Work @default.
• W4296301595 citedByCount "11" @default.
• W4296301595 countsByYear W42963015952022 @default.
• W4296301595 countsByYear W42963015952023 @default.
• W4296301595 crossrefType "journal-article" @default.
• W4296301595 hasAuthorship W4296301595A5002707772 @default.
• W4296301595 hasAuthorship W4296301595A5004722731 @default.
• W4296301595 hasAuthorship W4296301595A5016340857 @default.
• W4296301595 hasAuthorship W4296301595A5026031312 @default.
• W4296301595 hasAuthorship W4296301595A5029674394 @default.
• W4296301595 hasAuthorship W4296301595A5030343009 @default.
• W4296301595 hasAuthorship W4296301595A5035239568 @default.
• W4296301595 hasAuthorship W4296301595A5035353168 @default.
• W4296301595 hasAuthorship W4296301595A5038774828 @default.
• W4296301595 hasAuthorship W4296301595A5039732411 @default.
• W4296301595 hasAuthorship W4296301595A5039789130 @default.
• W4296301595 hasAuthorship W4296301595A5045935466 @default.
• W4296301595 hasAuthorship W4296301595A5049648116 @default.
• W4296301595 hasAuthorship W4296301595A5051530432 @default.
• W4296301595 hasAuthorship W4296301595A5053194091 @default.
• W4296301595 hasAuthorship W4296301595A5056664302 @default.
• W4296301595 hasAuthorship W4296301595A5057812039 @default.
• W4296301595 hasAuthorship W4296301595A5059011787 @default.
• W4296301595 hasAuthorship W4296301595A5061359562 @default.
• W4296301595 hasAuthorship W4296301595A5061462083 @default.
• W4296301595 hasAuthorship W4296301595A5065253955 @default.
• W4296301595 hasAuthorship W4296301595A5069357648 @default.
• W4296301595 hasAuthorship W4296301595A5069456501 @default.
• W4296301595 hasAuthorship W4296301595A5069601173 @default.
• W4296301595 hasAuthorship W4296301595A5071273910 @default.
• W4296301595 hasAuthorship W4296301595A5073951189 @default.
• W4296301595 hasAuthorship W4296301595A5076782898 @default.
• W4296301595 hasAuthorship W4296301595A5091301686 @default.
• W4296301595 hasAuthorship W4296301595A5091436608 @default.
• W4296301595 hasBestOaLocation W42963015951 @default.
• W4296301595 hasConcept C126322002 @default.
• W4296301595 hasConcept C164705383 @default.
• W4296301595 hasConcept C197934379 @default.
• W4296301595 hasConcept C2777698277 @default.

• next